Suchen
Stryker Corp
SYKZur Watchlist hinzufügen
302.105USD
+7.655+2.60%
Handelsschluss 05/13, 16:00（ET）Kurse um 15 Minuten verzögert
115.83BMarktkapitalisierung
34.62KGV TTM
mehr Informationen über Stryker Corp Unternehmen
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Stryker Corp Informationen
BörsenkürzelSYK
Name des UnternehmensStryker Corp
IPO-datumMar 17, 1980
CEOLobo (Kevin A)
Anzahl der mitarbeiter53000
WertpapierartOrdinary Share
GeschäftsjahresendeMar 17
Addresse1941 Stryker Way
StadtPORTAGE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl49002
Telefon12693852600
Websitehttps://www.stryker.com/
BörsenkürzelSYK
IPO-datumMar 17, 1980
CEOLobo (Kevin A)
Führungskräfte von Stryker Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
222.95K
+11.34%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
79.30K
+10.91%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
38.16K
-32.25%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.64%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
17.58K
+27.71%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
12.82K
+36.42%
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
6.47K
+1.44%
Mr. Preston W. Wells
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
5.91K
-3.45%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.87K
+1.58%
Dr. Giovanni Caforio, M.D.
Dr. Giovanni Caforio, M.D.
Independent Director
Independent Director
2.89K
+3.22%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
222.95K
+11.34%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
79.30K
+10.91%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
38.16K
-32.25%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.64%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
17.58K
+27.71%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
12.82K
+36.42%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medical
4.20B
16.74%
Trauma and Extremities
3.95B
15.72%
Endoscopy
3.81B
15.16%
Instruments
3.18B
12.67%
Knees
2.66B
10.57%
Andere
7.32B
29.14%
Nach RegionUSD
Name
Umsatz
Anteil
United States
19.01B
75.67%
Europe & Middle East & Africa (EMEA) (Region)
3.18B
12.67%
Asia Pacific (Region)
2.16B
8.62%
Other countries
765.00M
3.05%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medical
4.20B
16.74%
Trauma and Extremities
3.95B
15.72%
Endoscopy
3.81B
15.16%
Instruments
3.18B
12.67%
Knees
2.66B
10.57%
Andere
7.32B
29.14%
Aktionärsstatistik
Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Vanguard Capital Management, LLC
5.84%
Brown (John W)
5.23%
BlackRock Institutional Trust Company, N.A.
4.39%
Greenleaf Trust
4.16%
State Street Investment Management (US)
3.98%
Andere
76.40%
Aktionäre
Aktionäre
Anteil
Vanguard Capital Management, LLC
5.84%
Brown (John W)
5.23%
BlackRock Institutional Trust Company, N.A.
4.39%
Greenleaf Trust
4.16%
State Street Investment Management (US)
3.98%
Andere
76.40%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
45.14%
Investment Advisor/Hedge Fund
21.50%
Bank and Trust
6.47%
Individual Investor
5.39%
Research Firm
3.39%
Pension Fund
2.17%
Hedge Fund
1.44%
Sovereign Wealth Fund
1.40%
Family Office
0.13%
Andere
12.99%
Institutionelle Beteiligung
Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
3695
312.34M
81.56%
-3.59M
2025Q4
3571
314.41M
82.22%
-3.81M
2025Q3
3494
311.59M
81.48%
-5.78M
2025Q2
3464
329.22M
86.11%
-1.59M
2025Q1
3477
331.34M
86.70%
+478.07K
2024Q4
3392
326.31M
85.52%
-6.25M
2024Q3
3219
327.28M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.55M
2023Q4
3047
327.61M
86.24%
+19.84M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Brown (John W)
20.06M
5.24%
--
--
Feb 28, 2026
BlackRock Institutional Trust Company, N.A.
16.84M
4.4%
+573.61K
+3.53%
Dec 31, 2025
Greenleaf Trust
15.31M
4%
-1.25M
-7.55%
Feb 28, 2026
State Street Investment Management (US)
15.25M
3.98%
+311.51K
+2.08%
Dec 31, 2025
T. Rowe Price Associates, Inc.
9.61M
2.51%
-872.48K
-8.33%
Dec 31, 2025
JP Morgan Asset Management
8.00M
2.09%
+868.19K
+12.17%
Dec 31, 2025
Geode Capital Management, L.L.C.
7.54M
1.97%
+69.85K
+0.94%
Dec 31, 2025
Wellington Management Company, LLP
6.49M
1.7%
+1.20M
+22.64%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Jensen Quality Growth ETF
6.01%
iShares U.S. Medical Devices ETF
4.17%
AdvisorShares Focused Equity ETF
3.62%
Gabelli Growth Innovators ETF
3%
Global X Aging Population ETF
2.85%
Hennessy Sustainable ETF
2.77%
Knowledge Leaders Developed World ETF
2.73%
Health Care Select Sector SPDR Fund
2.51%
Proshares Ultra Health Care
2.42%
iShares U.S. Healthcare ETF
2.4%
Mehr Anzeigen
Jensen Quality Growth ETF
Anteil6.01%
iShares U.S. Medical Devices ETF
Anteil4.17%
AdvisorShares Focused Equity ETF
Anteil3.62%
Gabelli Growth Innovators ETF
Anteil3%
Global X Aging Population ETF
Anteil2.85%
Hennessy Sustainable ETF
Anteil2.77%
Knowledge Leaders Developed World ETF
Anteil2.73%
Health Care Select Sector SPDR Fund
Anteil2.51%
Proshares Ultra Health Care
Anteil2.42%
iShares U.S. Healthcare ETF
Anteil2.4%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
4.36B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
May 07, 2026
SYK.NB Interim Cash Dividend of gross USD 0.88 paid on Jul 31, 2026 going ex on Jun 30, 2026
Jun 30, 2026
Jul 31, 2026
Jun 30, 2026
Feb 04, 2026
SYK.NB Interim Cash Dividend of gross USD 0.88 paid on Apr 30, 2026 going ex on Mar 31, 2026
Mar 31, 2026
Apr 30, 2026
Mar 31, 2026
Dec 11, 2025
SYK.NB Final Cash Dividend of gross USD 0.88 paid on Jan 30, 2026 going ex on Dec 31, 2025
Dec 31, 2025
Jan 30, 2026
Dec 31, 2025
Aug 07, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Oct 31, 2025 going ex on Sep 30, 2025
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 08, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Jul 31, 2025 going ex on Jun 30, 2025
Jun 30, 2025
Jul 31, 2025
Jun 30, 2025
Feb 05, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Mehr Anzeigen
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
